Boston Scientific Corporation Share Price
Stocks
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
21:00:02 11/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 45.13 USD | +0.96% |
|
-1.51% | -52.67% |
| Market Cap | 65.41B 58.96B 54.47B 49.24B 93.16B 6,135B 95.46B 653B 260B 3,286B 246B 240B 10,457B | P/E 2026 * |
18.4x | P/E 2027 * | 19.7x |
|---|---|---|---|---|---|
| Enterprise Value | 75.9B 68.41B 63.2B 57.13B 108B 7,119B 111B 757B 302B 3,812B 285B 279B 12,133B | EV / Sales 2026 * |
3.62x | EV / Sales 2027 * | 3.49x |
| Free-Float |
82.48% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
|
Tradegate
| BSX | Real-time | |
|
Börse Stuttgart
| BSX | Delayed | |
|
London S.E.
| 0HOY | Delayed | |
|
Boerse Muenchen
| BSX | Real-time | |
|
Mexican S.E.
| BSX * | End-of-day quote | |
|
Xetra
| BSX | Delayed | |
|
CBOE
| Real-time | ||
|
Borsa Italiana
| 1BSX | End-of-day quote | |
|
Wiener Boerse
| BSXC | End-of-day quote | |
|
Deutsche Boerse AG
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
CBOE
| 0HOY | Real-time | |
|
Bulgaria S.E.
| BSX | End-of-day quote |
Last Transcript: Boston Scientific Corporation
| 1 day | +0.96% | ||
| 1 week | -1.51% | ||
| Current month | +7.50% | ||
| 1 month | +5.62% | ||
| 3 months | -11.84% | ||
| 6 months | -15.44% | ||
| Current year | -52.67% |
| 1 week | 42.69 |  | 45.82 |
| 1 month | 39.57 | | 46.97 |
| Current year | 39.57 | | 100.9 |
| 1 year | 39.57 | | 105.65 |
| 3 years | 39.57 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 31/10/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 29/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 02/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 28/02/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 14/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/11/26 | Don | Chief Executive Officer | 252,241 | 0.0171% | ||
| 01/11/26 | Exercice | Head of Human Resources | 9,614 | 0.0007% | ||
| 25/08/26 | Buy | Director | 2,040 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.96% | -1.51% | -55.97% | -12.47% | 64.79B | |
| -0.07% | +1.64% | +22.37% | +60.05% | 266B | |
| -0.34% | +0.16% | +9.05% | +19.45% | 166B | |
| -0.11% | -6.76% | -21.43% | +62.00% | 156B | |
| +1.73% | +6.48% | +24.25% | +64.79% | 59.81B | |
| +1.35% | -2.97% | -2.05% | -8.59% | 53.3B | |
| -0.52% | -0.12% | +18.42% | +63.13% | 50.15B | |
| -0.26% | -1.89% | +1.90% | +84.62% | 49.47B | |
| -0.97% | +0.71% | +21.95% | +84.00% | 46.72B | |
| -1.26% | -3.74% | +12.52% | +18.81% | 37.82B | |
| Average | +0.04% | -0.52% | +3.10% | +43.58% | 95B | |
| Weighted average by Cap. | -0.00% | -0.53% | +4.57% | +45.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 20.97B 18.9B 17.46B 15.78B 29.86B 1,967B 30.6B 209B 83.4B 1,053B 78.7B 77.02B 3,352B | 20.88B 18.82B 17.38B 15.72B 29.73B 1,958B 30.47B 208B 83.04B 1,049B 78.36B 76.69B 3,337B |
| Net income | 3.53B 3.18B 2.94B 2.66B 5.03B 331B 5.15B 35.25B 14.05B 177B 13.26B 12.97B 565B | 3.27B 2.95B 2.72B 2.46B 4.66B 307B 4.77B 32.65B 13.01B 164B 12.28B 12.02B 523B |
| Net Debt | 10.48B 9.45B 8.73B 7.89B 14.93B 983B 15.3B 105B 41.7B 527B 39.35B 38.51B 1,676B | 7.39B 6.66B 6.15B 5.56B 10.52B 693B 10.78B 73.73B 29.39B 371B 27.73B 27.14B 1,181B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/11/26 | US$45.13 | +0.96% | 17,779,628 |
| 10/11/26 | US$44.70 | +1.54% | 11,713,596 |
| 09/11/26 | US$44.02 | +2.97% | 16,195,827 |
| 06/11/26 | US$42.75 | -4.23% | 14,712,591 |
| 05/11/26 | US$44.64 | -2.58% | 22,492,478 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
